These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2831711)

  • 1. Hemolytic uremic syndrome in a patient with small cell lung cancer.
    Avvento L; Gordon S; Silberberg JM; Zarrabi MH; Zucker S
    Am J Hematol; 1988 Mar; 27(3):221-3. PubMed ID: 2831711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmapheresis as a therapeutic measure in hemolytic-uremic syndrome in children.
    Gillor A; Bulla M; Roth B; Bussmann K; Schrör K; Tekook A; Gladtke E
    Klin Wochenschr; 1983 Apr; 61(7):363-7. PubMed ID: 6345920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Microangiopathic hemolytic anemias. Clinical pattern, therapy and clinical course in 14 patients with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome].
    Krause M; Fehr J; Gmür J; Keusch G; Frick P; Oelz O
    Schweiz Med Wochenschr; 1986 Nov; 116(48):1666-74. PubMed ID: 3798063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus (FK506) associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in lung transplant salvage with a plasmapheresis and cyclosporin.
    Boctor FN
    Egypt J Immunol; 2006; 13(2):95-9. PubMed ID: 18689275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impairment of platelet aggregation in hemolytic uremic syndrome: evidence for platelet "exhaustion".
    Fong JS; Kaplan BS
    Blood; 1982 Sep; 60(3):564-70. PubMed ID: 6213275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemolytic-uraemic syndrome: deficiency of plasma factor(s) regulating prostacyclin activity?
    Remuzzi G; Misiani R; Marchesi D; Livio M; Mecca G; de Gaetano G; Donati MB
    Lancet; 1978 Oct; 2(8095):871-2. PubMed ID: 81415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prostacyclin in the treatment of hemolytic-uremic syndrome: apropos of a case].
    Series C; Level C; Guez S; Morel D; Vincent MP; Bigourdan V; Fabry V; Dutronc H; Potaux L
    Rev Med Interne; 1996; 17(1):76-8. PubMed ID: 8677389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of plasmapheresis in the treatment of hemolytic-uremic syndrome in children].
    Salvatori G; Rinaldi S; Landolfo A; Totino T; Salvatori A; Signoretti A
    Pediatr Med Chir; 1986; 8(3):383-7. PubMed ID: 3786202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement dysfunction in hemolytic uremic syndrome.
    Zipfel PF; Skerka C
    Curr Opin Rheumatol; 2006 Sep; 18(5):548-55. PubMed ID: 16896298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of hemolytic uremic syndrome accompanied by massive proteinuria and ascites].
    Ookawara S; Saitou M; Suzuki M; Imai H
    Nihon Jinzo Gakkai Shi; 1996 Feb; 38(2):98-102. PubMed ID: 8717312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful management of thrombocytopenia, microangiopathic anemia, and acute renal failure by plasmapheresis.
    Hakim RM; Schulman G; Churchill WH; Lazarus JM
    Am J Kidney Dis; 1985 Mar; 5(3):170-6. PubMed ID: 4038847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features, therapeutic interventions and long-term aspects of hemolytic-uremic syndrome in Norwegian children: a nationwide retrospective study from 1999-2008.
    Jenssen GR; Vold L; Hovland E; Bangstad HJ; Nygård K; Bjerre A
    BMC Infect Dis; 2016 Jun; 16():285. PubMed ID: 27297224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelets, endothelium, and renal disease.
    Lancet; 1979 Oct; 2(8148):890-1. PubMed ID: 90975
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemolytic-uremic syndrome: demonstration of abnormalities of platelet reactivity and insensitivity to prostaglandin I2.
    Bloom A; Hannaford PA; Greaves M; Preston FE; Brown CB
    Clin Nephrol; 1985 Feb; 23(2):85-8. PubMed ID: 3886228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy.
    Cantrell JE; Phillips TM; Schein PS
    J Clin Oncol; 1985 May; 3(5):723-34. PubMed ID: 3923162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of the hemolytic-uremic syndrome with inhibitors of platelet function.
    Thorsen CA; Rossi EC; Green D; Carone FA
    Am J Med; 1979 Apr; 66(4):711-6. PubMed ID: 433976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adult hemolytic-uremic syndrome: successful treatment with plasmapheresis.
    Cattran DC
    Am J Kidney Dis; 1984 Jan; 3(4):275-9. PubMed ID: 6362404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis and clinical features of hemolytic uremic syndrome].
    Nakajima M; Yoshioka A
    Nihon Rinsho; 1993 Jan; 51(1):210-4. PubMed ID: 8433521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired and exhausted platelets in modified generalized Shwartzman reaction: an analogue of hemolytic uremic syndrome associated with endotoxemia.
    Fong JS; King-Hrycaj BD
    J Lab Clin Med; 1983 Dec; 102(6):847-57. PubMed ID: 6644155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of plasma antifibrin/fibrinogen antibodies in a patient with hemolytic uremic syndrome.
    Rock G; Kolajova M; Faught C; Zimmerman D
    Blood Coagul Fibrinolysis; 2006 Oct; 17(7):539-44. PubMed ID: 16988548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.